In a unanimous decision released Thursday, the Supreme Court held that a group challenging the Food and Drug Administration's release of the abortion drug mifepristone did not have standing to sue.
“Under Article III of the Constitution, a plaintiff’s desire to make a drug less available for others does not establish standing to sue," Justice Brett Kavanaugh wrote. "Nor do the plaintiffs’ other standing theories suffice."
The lawsuit in question came from anti-abortion doctors in Texas who argued the FDA had not done enough to ensure the safety of the drug before it was approved decades ago.
Want more breaking political news? Click for the latest headlines at Raw Story.
None of the doctors had ever used the drug in their practice, however. So, one of the arguments of the FDA is that they didn't have standing in the case.
The term "pro-life" was used frequently in the ruling to describe the plaintiffs in the case.
On Thursday, the Supreme Court agreed, overturning a lower-court ruling by far-right U.S. District Judge Matthew J. Kacsmaryk.